Sign in
4

Changes in Ownership

Citius Pharmaceuticals, Inc. Filed Acc 0001013762-23-003528

Options or other derivatives

  • Chief Executive Officer acquired 550,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mazur Leonard L · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-10 Grant or award : show line 1 in the form Option to Purchase Common Stock +550,000 550,000 D
Loading xslF345X05/ownership.xml…